ALMS
Price
$4.35
Change
+$0.15 (+3.57%)
Updated
Aug 6, 04:21 PM (EDT)
Capitalization
433.39M
13 days until earnings call
OABI
Price
$1.93
Change
-$0.12 (-5.88%)
Updated
Aug 6, 04:47 PM (EDT)
Capitalization
249.56M
Interact to see
Advertisement

ALMS vs OABI

Header iconALMS vs OABI Comparison
Open Charts ALMS vs OABIBanner chart's image
Alumis
Price$4.35
Change+$0.15 (+3.57%)
Volume$500
Capitalization433.39M
OmniAb
Price$1.93
Change-$0.12 (-5.88%)
Volume$1.15K
Capitalization249.56M
ALMS vs OABI Comparison Chart in %
Loading...
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALMS vs. OABI commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALMS is a Buy and OABI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (ALMS: $4.20 vs. OABI: $2.04)
Brand notoriety: ALMS and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALMS: 57% vs. OABI: 34%
Market capitalization -- ALMS: $433.39M vs. OABI: $249.56M
ALMS [@Biotechnology] is valued at $433.39M. OABI’s [@Biotechnology] market capitalization is $249.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALMS’s FA Score shows that 0 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • ALMS’s FA Score: 0 green, 5 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALMS and OABI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALMS’s TA Score shows that 4 TA indicator(s) are bullish while OABI’s TA Score has 3 bullish TA indicator(s).

  • ALMS’s TA Score: 4 bullish, 4 bearish.
  • OABI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALMS is a better buy in the short-term than OABI.

Price Growth

ALMS (@Biotechnology) experienced а +6.33% price change this week, while OABI (@Biotechnology) price change was -0.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.67%. For the same industry, the average monthly price growth was +14.79%, and the average quarterly price growth was +13.41%.

Reported Earning Dates

ALMS is expected to report earnings on Aug 19, 2025.

OABI is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-0.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALMS($433M) has a higher market cap than OABI($250M). OABI YTD gains are higher at: -42.373 vs. ALMS (-46.565). OABI has higher annual earnings (EBITDA): -47.42M vs. ALMS (-354.69M). ALMS has more cash in the bank: 209M vs. OABI (43.6M). OABI has less debt than ALMS: OABI (22.5M) vs ALMS (31.9M). OABI has higher revenues than ALMS: OABI (26.7M) vs ALMS (17.4M).
ALMSOABIALMS / OABI
Capitalization433M250M173%
EBITDA-354.69M-47.42M748%
Gain YTD-46.565-42.373110%
P/E RatioN/AN/A-
Revenue17.4M26.7M65%
Total Cash209M43.6M479%
Total Debt31.9M22.5M142%
TECHNICAL ANALYSIS
Technical Analysis
ALMSOABI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
50%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
43%
Advances
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSQTF0.230.05
+29.91%
Victory Square Technologies Inc
COVUX13.06N/A
N/A
Columbia Overseas Value R
PKTEF0.44N/A
N/A
Parkit Enterprise Inc.
TKCBY22.95N/A
N/A
Tokai Carbon Company Ltd.
BDHCX8.78-0.01
-0.11%
BlackRock Dynamic High Income Inv C

ALMS and

Correlation & Price change

A.I.dvisor tells us that ALMS and ADAP have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALMS and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALMS
1D Price
Change %
ALMS100%
+2.69%
ADAP - ALMS
29%
Poorly correlated
+19.92%
ATXS - ALMS
26%
Poorly correlated
+1.89%
HALO - ALMS
23%
Poorly correlated
+1.37%
CCCC - ALMS
23%
Poorly correlated
-4.29%
OABI - ALMS
23%
Poorly correlated
+4.62%
More

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with BEAM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+4.62%
BEAM - OABI
44%
Loosely correlated
-2.20%
NTLA - OABI
40%
Loosely correlated
-4.46%
RXRX - OABI
40%
Loosely correlated
-4.66%
ALEC - OABI
40%
Loosely correlated
+0.65%
CRBU - OABI
39%
Loosely correlated
-2.86%
More